110 related articles for article (PubMed ID: 32557555)
1. Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia.
Favresse J; Eucher C; Elsen M; Graux C; Goebels P; Laffineur K; Nicolas JB; Dogné JM; Douxfils J
Br J Haematol; 2020 Aug; 190(4):e187-e189. PubMed ID: 32557555
[No Abstract] [Full Text] [Related]
2. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
Goetz L; Yang J; Greene W; Zhu Y
J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
[No Abstract] [Full Text] [Related]
3. COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia.
Langerbeins P; Fürstenau M; Gruell H; Klein F; Persigehl T; Rybniker J; Seeger-Nukpezah T; Kochanek M; Hallek M; Eichhorst B; Koehler P; Böll B
Eur J Haematol; 2020 Oct; 105(4):508-511. PubMed ID: 32575156
[TBL] [Abstract][Full Text] [Related]
4. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
Roeker LE; Knorr DA; Pessin MS; Ramanathan LV; Thompson MC; Leslie LA; Zelenetz AD; Mato AR
Leukemia; 2020 Nov; 34(11):3047-3049. PubMed ID: 32855439
[No Abstract] [Full Text] [Related]
5. Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia.
Ingelman-Sundberg HM; Blixt L; Wullimann D; Wu J; Gao Y; Healy K; Muschiol S; Bogdanovic G; Åberg M; Kjellander C; Grifoni A; Sette A; Aleman S; Chen P; Blennow O; Hansson L; Ljunggren HG; Chen MS; Buggert M; Österborg A
Haematologica; 2024 Feb; 109(2):646-651. PubMed ID: 37646668
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Mellinghoff SC; Mayer L; Robrecht S; Weskamm LM; Dahlke C; Gruell H; Schlotz M; Vanshylla K; Schloser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P
Haematologica; 2022 Oct; 107(10):2480-2484. PubMed ID: 35734927
[No Abstract] [Full Text] [Related]
7. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges.
Charra B; Ellouadghiri A; Magramane A; Kebbou T; Damaan K; Maghfour A; Seddiki K; Ezzouine H
Pan Afr Med J; 2020; 36():286. PubMed ID: 33117480
[TBL] [Abstract][Full Text] [Related]
9. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
Favresse J; Eucher C; Elsen M; Laffineur K; Dogné JM; Douxfils J
Clin Chem Lab Med; 2020 Sep; 58(10):e193-e196. PubMed ID: 32639942
[No Abstract] [Full Text] [Related]
10. Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Herishanu Y; Avivi I; Levi S; Shefer G; Bronstein Y; Moshiashvili MM; Ziv T; Scarfò L; Perry C; Ghia P
Blood Adv; 2022 Jan; 6(1):148-151. PubMed ID: 34614513
[No Abstract] [Full Text] [Related]
11. Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.
Morawska M
Eur J Haematol; 2022 Feb; 108(2):91-98. PubMed ID: 34717004
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of viral load and antibody response in relation to COVID-19 severity.
Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
[TBL] [Abstract][Full Text] [Related]
13. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.
Guisado-Vasco P; Carralón-González MM; Aguareles-Gorines J; Martí-Ballesteros EM; Sánchez-Manzano MD; Carnevali-Ruiz D; García-Coca M; Barrena-Puertas R; de Viedma RG; Luque-Pinilla JM; Sotres-Fernandez G; Fernández-Sousa JM; Luepke-Estefan XE; López-Martín JA; Jimeno JM
J Hematol Oncol; 2022 Jan; 15(1):4. PubMed ID: 35012608
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
[TBL] [Abstract][Full Text] [Related]
15. When CLL meets COVID-19.
Montserrat E
Blood; 2020 Sep; 136(10):1115-1116. PubMed ID: 32882019
[No Abstract] [Full Text] [Related]
16. The kinetics of viral load and antibodies to SARS-CoV-2.
Sun J; Tang X; Bai R; Liang C; Zeng L; Lin H; Yuan R; Zhou P; Huang X; Xiong Q; Peng J; Cui F; Ke B; Su J; Liu Z; Lu J; Tian J; Sun R; Ke C
Clin Microbiol Infect; 2020 Dec; 26(12):1690.e1-1690.e4. PubMed ID: 32898715
[TBL] [Abstract][Full Text] [Related]
17. Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients.
Mayanskiy N; Luchkina P; Fedorova N; Lebedin Y; Ponomareva N
Leukemia; 2021 Jun; 35(6):1820-1822. PubMed ID: 34007047
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Mellinghoff SC; Robrecht S; Mayer L; Weskamm LM; Dahlke C; Gruell H; Vanshylla K; Schlösser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P
Leukemia; 2022 Feb; 36(2):562-565. PubMed ID: 34937858
[No Abstract] [Full Text] [Related]
19. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
[TBL] [Abstract][Full Text] [Related]
20. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
